Customer-Driven Innovation: Exit the Vicious Circle of Failures

THE MANSFIELD BIO-INCUBATOR

Presents

Customer-Driven Innovation: Exit the Vicious Circle of Failures

So, you think you got a great product or technology?

BUT:

  • Investors are not impressed

  • Potential customers are not buying it

  • Development is not feasible or cost-prohibitive

 Learn how to avoid these pitfalls, right from the start!

Join us for the seminar and networking at the newly-opened Mansfield Bio-Incubator on July 25, 2017.

Directions and Parking: http://bit.ly/2sad3m9  Ample parking across from the entrance.

Program Description:

Moderator: 

Brian Shoemaker, PhD, Principal Consultant, ShoeBar Associates

Brian Shoemaker consults for healthcare products companies in computer system validation, software quality assurance, and electronic records and signatures. He has conducted validation both on product software and on internal software, developed software quality systems, audited software quality processes (including agile methodology), and evaluated 21 CFR Part 11 compliance. He has had clients in clinical diagnostics, medical device engineering, medical imaging, medical-device fabrics manufacturing, contract lyophilization, clinical trial software, dental prosthetics, and bone-repair implants. He has worked with companies in Germany and Switzerland as well as the U.S.

Previous to founding ShoeBar Associates, Brian had quality roles at PPD Informatics, Doxis, Inc., and Behring Diagnostics, Inc. Brian earned his Ph.D. in chemistry from the University of Illinois; he has achieved the ASQ Software Quality Engineer certification.

Panelists:

Jeffrey Thumm, President, Duke Devices, LLC

Mr. Thumm is an engineer, entrepreneur, and businessman with over 40 years of experience in new product development and in driving early-stage businesses.  Most of his work has been in medical devices, medical equipment, and chemical sensing and controls for chemical processing.  Mr. Thumm holds BSEE and MBA degrees and has seven patents granted in communications, non-linear sensors, and chemical processing. He is the inventor and patent holder for hydraulically-driven, intense-energy, in-line chemical mixer-reactors and for continuous-energy, particle-reduction processors. 

Through his career, Mr. Thumm has worked with over 30 early stage companies and formed three technology-based companies.  In collaboration with research doctors, PhD chemists and industrial R&D, Mr. Thumm's companies have developed instrumentation solutions for chemical sensing platforms, microfluidic-slide HIV detectors, and microfluidic disks for combinatorial chemistry.  Mr. Thumm's current work includes running a small team in developing a wireless sensor, data-to-cloud solution for remote applications such as pharma processing, agricultural and oil & gas. 

Sophie Chapelle, Managing Director, Golden Seeds

Ms. Chapelle currently works with two Angel Investment Networks: Golden Seeds, investing in women-lead businesses; and 37Angels, a women-only investment group; to review and select for-profit companies for seed investment. In addition, she is a Mentor at the MIT Enterprise Forum, Member of the Board for the National Biomedical Research Foundation (NBMRF) and as Strategic Advisor to Bentley College’s Center for Integration of Science and Industry (CISI). Ms. Chapelle leverages her 20+ years of experience in the business and operations of biopharmaceutical R&D with an academic educational background in business, finance, and operations from Columbia University and in chemical engineering and pharmacology from University of Brussels, Belgium (ULB) and Lille (France). Her credentials are rooted in 23+ years in roles of growing responsibilities in sales & marketing, strategy, financial, operations and people management in large companies such as Pfizer and UCB as well as several smaller organizations.

Richard C. Tharin, RAC, Tharin, Founder, The Cerneos Group, LLC

Mr. Tharin is a Biomedical Scientist and Regulatory Affairs Professional with over 30 years of experience in product development for biotech and medical device products.   His therapeutic experience includes vaccine and diagnostic development, oncology and infectious diseases.  As a scientist and regulatory professional, he has managed the transitions of many firms from start-up to clinical trial and production phases.   His work covers international business and product launches in the US, Latin America, Europe and Asia.  He holds a Bachelor’s Degree in Biology and a Master of Science Degree in Regulatory Affairs. He has developed a consulting firm dedicated to providing resources needed for developing firms from startup to commercialization phases. 

Mr. Tharin’s experience includes being a faculty member in regulatory affairs training programs, development of on-line courses.  He supports startup clients as a mentor in business incubators and accelerator programs.  Mr. Tharin’s current work includes the development of teams to make biologic, tissue culture and electromechanical device products.  As a trainer, he supports local STEM education initiatives at the State and Global level.  He is the founder in his current business, The Cerneos Group, LLC.

What Will You Learn?

Attendees will learn what questions they need to address, ideally before embarking on the product development, or if they hit a stumbling block along the way. In addition, the goal of the panel discussion is to help service providers such as law firms, CRO/CMOs, engineering firms, etc., on how to become not just service providers but also more effective partners and mentors to shorten the timelines and use the resources more efficiently, or in some cases when to "pull the plug" before it is too late.

Who Should Attend?

Life science (biotech, pharma, medical device) entrepreneurs, academic faculty or students/postdocs, scientists from large biotech/pharma/medical devices who would like to commercialize their discoveries.

For tickets and more information, please click here:

http://bit.ly/2syvi7f